Universal Biosensors, Inc. is a specialist medical diagnostics company. The Company is focused on the research, development and manufacture of in vitro diagnostic test devices for consumer and professional point-of-care use. The Company's subsidiary, Universal Biosensors Pty Ltd, conducts its research, development and manufacturing activities. The Company uses its electrochemical cell technology platform to develop point-of-care testing systems for a range of different markets. The Company is engaged in the development of its own Prothrombin Time International Normalized Ratio (PT-INR) test for use in decentralized settings, including the patient self-test market. It is engaged in demonstrating the various applications of its technology platform, including its application to diagnostic tests based on enzymatic, immunoassay and molecular diagnostic methods. It has developed a blood glucose test with LifeScan, Inc. and a coagulation PT-INR test with Siemens Healthcare Diagnostics Inc.